Also trades as: 4503.T (JPX) · $vol 92M · ALPMY (OTC) · $vol 2M

$14.37

-0.30 (-2.06%)

Weekly Expected Move ±11.1%

$11 $13 $14 $16 $18

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 47 · $25.7B mcap · 1.72B float · 0.0002% daily turnover · Short 45% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$2.15T +12.6% ▲

5Y CAGR: +11.5%

Gross Profit

$1.60T +2.7% ▲

5Y CAGR: +9.8%

Operating Income

$422.3B +929.1% ▲

5Y CAGR: +25.4%

Net Income

$293.4B +478.1% ▲

5Y CAGR: +19.5%

EPS (Diluted)

$162.98 +477.1% ▲

5Y CAGR: +20.2%

EBITDA

$618.2B +149.2% ▲

5Y CAGR: +13.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.30T	$1.52T	$1.60T	$1.91T	$2.15T
YoY Growth	+3.7%	+17.2%	+5.6%	+19.2%	+12.6%
Cost of Revenue	$253.0B	$288.4B	$292.5B	$349.2B	$547.8B
Gross Profit	$1.04T	$1.23T	$1.31T	$1.56T	$1.60T
Gross Margin	80.5%	81.0%	81.8%	81.7%	74.6%
R&D Expenses	$246.0B	$276.1B	$294.2B	$327.7B	$316.8B
SG&A Expenses	$548.8B	$630.3B	$740.1B	$843.0B	$865.7B
Operating Expenses	$823.1B	$944.8B	$1.29T	$1.52T	$1.18T
Operating Income	$220.0B	$133.0B	$25.5B	$41.0B	$422.3B
Operating Margin	17.0%	8.8%	1.6%	2.1%	19.6%
Interest Expense	$4.9B	$8.8B	$12.0B	$17.7B	$14.2B
Income Before Tax	$156.9B	$132.4B	$25.0B	$31.2B	$379.0B
Tax Expense	$32.8B	$33.6B	$7.9B	-$19.5B	$85.5B
Net Income	$124.1B	$98.7B	$17.0B	$50.7B	$293.4B
Net Margin	9.6%	6.5%	1.1%	2.7%	13.6%
EPS (Diluted)	$67.05	$54.09	$9.47	$28.24	$162.98
EBITDA	$297.8B	$337.4B	$194.8B	$248.0B	$618.2B
Shares Outstanding	1.85B	1.83B	1.80B	1.80B	1.80B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$473.1B	$462.5B	$517.4B	$459.3B	$505.8B	$531.8B	$571.7B	$541.3B
Cost of Revenue	$91.1B	$82.7B	$98.5B	$76.9B	$94.8B	$140.2B	$149.3B	$130.2B
Gross Profit	$382.0B	$379.8B	$418.9B	$382.4B	$411.0B	$391.6B	$422.4B	$411.1B
Gross Margin	80.7%	82.1%	81.0%	83.3%	81.3%	73.6%	73.9%	75.9%
R&D Expenses	$86.8B	$85.5B	$79.1B	$76.2B	$71.7B	$72.6B	$75.7B	$96.5B
SG&A Expenses	$206.9B	$199.5B	$225.3B	$211.3B	$197.0B	$209.8B	$222.0B	$236.2B
Operating Expenses	$331.3B	$316.6B	$535.1B	$318.9B	$316.3B	$282.4B	$297.6B	$332.7B
Operating Income	$50.7B	$63.2B	-$116.2B	$63.5B	$94.6B	$109.2B	$124.8B	$78.3B
Operating Margin	10.7%	13.7%	-22.5%	13.8%	18.7%	20.5%	21.8%	14.5%
Interest Expense	$4.5B	$4.5B	$2.2B	$3.0B	$4.2B	$2.7B	$2.4B	$3.1B
Income Before Tax	$50.5B	$38.5B	-$118.4B	$60.6B	$90.4B	$105.7B	$134.1B	$48.3B
Tax Expense	$12.9B	$2.6B	-$20.7B	-$14.3B	$22.0B	$25.3B	$33.7B	$4.4B
Net Income	$37.6B	$35.9B	-$97.7B	$74.9B	$68.4B	$80.3B	$100.4B	$43.9B
Net Margin	7.9%	7.8%	-18.9%	16.3%	13.5%	15.1%	17.6%	8.1%
EPS (Diluted)	$20.94	$19.97	$-54.57	$41.19	$38.11	$44.69	$55.90	$23.97
EBITDA	$103.6B	$88.0B	$126.1B	$101.8B	$151.8B	$156.4B	$185.7B	$129.0B
Shares Outstanding	1.80B	1.80B	1.79B	1.82B	1.80B	1.80B	1.80B	1.80B

ALPMF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet